Unexpectedly, patients with MM and APC/CTNNB1 genetic aberrations demonstrate a slightly higher frequency and early (i.e., within the first six months) development of melanoma brain metastases (MBMs) compared to patients without. The gene discussed is APC; the disease is Miyoshi myopathy.